News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Matrix Surgical To Become Exclusive Worldwide Licensee For Patent-Pending Craniofacial Implant System



3/17/2014 10:56:59 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ATLANTA, GA--(Marketwired - March 14, 2014) -

Matrix Surgical USA (www.matrixsurgicalusa.com), a leader in the development, manufacturing and commercialization of craniomaxillofacial implants, announced today that it has entered into a definitive agreement with Dr. Michael J. Yaremchuk to license a patent-pending craniofacial implant system (US patent application 20120330427).

Under the terms of the agreement, Matrix Surgical USA will use its proprietary technology to manufacture implants designed by Dr. Yaremchuk for use in craniofacial reconstruction and augmentation procedures. Through the collaboration, Dr. Yaremchuk and Matrix Surgical USA will use their complementary clinical and engineering capabilities to develop and manufacture next-generation implant shapes that provide better outcomes for plastic surgeons and their patients.

"We are excited to extend our working relationship with Dr. Yaremchuk," said John O'Shaughnessy, Founder and Chief Executive Officer of Matrix Surgical USA. "Building stronger collaborative relationships with leading surgeons like Dr. Yaremchuk is important to the Company's future. This relationship expands our opportunities to deliver best-in-class products and fits well with Dr. Yaremchuk's clinical practice to provide leading-edge solutions to improve people's lives."

The suite of implants designed by Dr. Yaremchuk and manufactured by the Company will be marketed under the OMNIPORE® brand and sold worldwide through Matrix Surgical USA's global distribution network.

Manufactured in the USA, OMNIPORE High-density Porous Polyethylene craniofacial implants are used for reconstructive and aesthetic craniofacial surgery, have FDA clearance and CE Mark approval, and the company is ISO 13485:2003 certified.

About Matrix Surgical USA
Matrix Surgical USA is a privately owned American company dedicated to the design, production, marketing and distribution of sterile, biocompatible craniofacial implants. Matrix Surgical USA offers its products to healthcare providers in the United States and in more than 60 countries around the world. Learn more at www.MatrixSurgicalUSA.com.


Media Contact:
Lynn Hood
Email Contact
678-974-2623

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES